Metropolitan Life Insurance CO I Bio, Inc. Transaction History

Metropolitan Life Insurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$0.55 - $1.04 $34,610 - $65,446	-62,929 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$1.06 - $1.52 $66,704 - $95,652	62,929 New	62,929 $66,000
Q3 2021 Mar 30, 2023	BUY	$1.06 - $1.52 $2,902 - $4,161	2,738 Added 4.55%	62,929 $66,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $66,704 - $95,652	62,929 New	62,929 $67,000
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $73 - $99	-60 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$1.18 - $2.62 $71,025 - $157,700	60,191 New	60,191 $92.7 Million
Q1 2021 Mar 30, 2023	BUY	$1.18 - $2.62 $71,025 - $157,700	60,191 New	60,191 $92,000
Q1 2021 May 14, 2021	BUY	$1.18 - $2.62 $70 - $157	60 New	60 $93,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.